Health Management

Inherited susceptibilities to leukemias are becoming better understood and have important implications for screening, prevention, genetic counseling, and treatment.

Plans and PBMs are finding new ways to rein in pharmacy costs.

In this Q&A, a physician and lymphoma expert discusses treatment advances and promising signs for the future.

Novel immunotherapy treatments are showing promise for patients with acute lymphoblastic leukemia (ALL), but they can trigger cytokine release syndrome.

Joint ventures are gaining steam as health plans and providers look for new ways to work together.

Two experts discuss top-of-mind women’s healthcare issues in managed care.

From “all-in-one” healthcare appointments to coordinating women’s care for convenience, here’s how providers and researchers say plans and providers can prioritize

The Independence Blue Cross Foundation Healthy Hearts Initiative aims to improve survival rates for sudden cardiac arrest, increase CPR preparedness.

As fee-for-service rapidly transforms into value-based care, the industry must improve member engagement and outcomes by using targeted care management interventions that help deliver bottom-line results across a broader spectrum of the population.

The path to bundled payment success can be daunting. Here’s three universal concepts that will promote success under the various CMS models.

Retail clinics emerge as a way to satisfy the growing demand for healthcare created by the newly insured under the ACA, but contrary to expectations, they do not appear to be leading to meaningful reductions in low-acuity ED visits.

: Remembering to engage in healthy behavior can often slip to the bottom of our list of priorities. In a world where we need to be reminded and motivated to be the healthiest version of ourselves, the right nudges at the right time can help us get there.

Humana’s value-based reimbursement model with physicians has helped to improve care quality and health outcomes for its Medicare Advantage (MA) program members.

The results of Geneia’s year-long study – a savings of $8,375 per patient and a slowing of disease progression – demonstrate that remote patient monitoring is a wise investment for payers.

Study examines the effectiveness of the Walgreens Connected Care CF program compared to a matched sample of control patients.

Alcohol and drug dependency treatment goals can tied to an insurer’s pay-for-performance incentive program. Here’s how.

Here are some of the latest precision medicine approaches being used by managed care organizations, health systems and academic medical centers across the U.S.

As the industry moves toward value-based care, medical education must keep pace.

After carefully considering its promise and consulting with experts, Independence Blue Cross this year became the first major insurer to provide coverage for certain members who are seeking access to whole genome sequencing.

Health plans are using advanced analytics to improve physician engagement,performance and satisfaction in ACOs and risk-sharing contracts.

The Cancer MoonShot 2020 program brings together stakeholders from pharma, community and academic oncology, as well as government and scientific communities in an effort to accelerate the potential of combination immunotherapy as the next-generation standard of care in cancer patients.

Drugs will be provided to health plan members on clinical trials free of charge.

Cancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.

The precision medicine effort could dramatically change patient care, but will it be effective?

A new cancer database, the Genomic Data Commons, aims to make research more accessible